General MedicationsORALStandard
VOQUEZNA
VONOPRAZAN FUMARATE
Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VOQUEZNA is listed in Drugs@FDA under application 218710 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient VONOPRAZAN FUMARATE Form and strength TABLET; ORAL - EQ 20MG BASE Sponsor PHATHOM PHARMACEUTICALS INC Submission history Latest submission status date: 2024-07-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview VOQUEZNA is listed in Drugs@FDA under application 218710 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VONOPRAZAN FUMARATE Form and strength TABLET; ORAL - EQ 20MG BASE Sponsor PHATHOM PHARMACEUTICALS INC Submission history Latest submission status date: 2024-07-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.